Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver M Fischer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Reviews. Cancer|May 4, 2004
The discovery of receptor tyrosine kinases: targets for cancer therapyAndreas Gschwind, Oliver M Fischer, Axel Ullrich
Cancer Research|March 18, 2004
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptorStefan Hart, Oliver M Fischer, Axel Ullrich
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Dissecting the epidermal growth factor receptor signal transactivation pathwayOliver M Fischer, Stefan Hart, Axel Ullrich
Discovery Medicine|August 14, 2010
Cell surface growth factor receptor molecules as targets for cancer therapyOliver M Fischer, Andreas Gschwind, Axel A Ullrich
Current Opinion in Chemical Biology|August 28, 2003
Beyond Herceptin and GleevecOliver M Fischer, Sylvia Streit, Stefan Hart, et al.
The EMBO Journal|May 14, 2003
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cellsAndreas Gschwind, Stefan Hart, Oliver M Fischer, et al.
The Journal of Biological Chemistry|May 5, 2004
Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cellsOliver M Fischer, Silvia Giordano, Paolo M Comoglio, et al.
Molecular and Cellular Biology|June 1, 2004
Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factorOliver M Fischer, Stefan Hart, Andreas Gschwind, et al.
Human Reproduction (Oxford, England)|June 7, 2013
BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapiesAndrea Wagenfeld, Wilhelm Bone, Wolfgang Schwede, et al.
Biological Chemistry|September 17, 2005
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathwaysStefan Hart, Oliver M Fischer, Norbert Prenzel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Reviews. Cancer|May 4, 2004
The discovery of receptor tyrosine kinases: targets for cancer therapyAndreas Gschwind, Oliver M Fischer, Axel Ullrich
Cancer Research|March 18, 2004
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptorStefan Hart, Oliver M Fischer, Axel Ullrich
Methods in Molecular Biology (Clifton, N.J.)|June 20, 2006
Dissecting the epidermal growth factor receptor signal transactivation pathwayOliver M Fischer, Stefan Hart, Axel Ullrich
Discovery Medicine|August 14, 2010
Cell surface growth factor receptor molecules as targets for cancer therapyOliver M Fischer, Andreas Gschwind, Axel A Ullrich
Current Opinion in Chemical Biology|August 28, 2003
Beyond Herceptin and GleevecOliver M Fischer, Sylvia Streit, Stefan Hart, et al.
The EMBO Journal|May 14, 2003
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cellsAndreas Gschwind, Stefan Hart, Oliver M Fischer, et al.
The Journal of Biological Chemistry|May 5, 2004
Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cellsOliver M Fischer, Silvia Giordano, Paolo M Comoglio, et al.
Molecular and Cellular Biology|June 1, 2004
Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factorOliver M Fischer, Stefan Hart, Andreas Gschwind, et al.
Human Reproduction (Oxford, England)|June 7, 2013
BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapiesAndrea Wagenfeld, Wilhelm Bone, Wolfgang Schwede, et al.
Biological Chemistry|September 17, 2005
GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathwaysStefan Hart, Oliver M Fischer, Norbert Prenzel, et al.
Pageof 2